Article Details
Retrieved on: 2019-03-28 19:00:48
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Baupost Group</b> LLC MA purchased a new position in shares of Akebia Therapeutics in the fourth quarter worth $135,327,000. Morgan Stanley ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here